Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Plus Docetaxel vs S-1 Plus Oxaliplatin in Gastric Cancer
NCT03961867Phase 3Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in gastric cancer (GC), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03961867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961867.